Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study
Immune-checkpoint inhibitors may provide long-term survival benefits via a cured proportion, yet data are usually insufficient to prove this upon submission to health technology assessment bodies.
Source: Value in Health - Category: International Medicine & Public Health Authors: Ash Bullement, Nicholas R. Latimer, Helen Bell Gorrod Source Type: research
More News: Cancer | Cancer & Oncology | Immunotherapy | International Medicine & Public Health | Study